Older people with bowel disease receive older medicines

November 13, 2017

Inflammatory bowel disease is common amongst older people and there are big differences in the choice of treatment for different age groups. Patients over the age of 60 often receive cortisone drugs instead of more modern medicines that target the immune system. This according to a large registry study from Karolinska Institutet in Sweden published in Gastroenterology.

Inflammatory bowel disease includes Crohn's disease, which can affect the whole intestine, and , which affects the colon and rectum. Symptoms include blood in the stool, diarrhoea and . Treatment consists of and surgery to remove the damaged part of the intestines. The most common age of onset is 20-30, and previous studies have claimed that it is uncommon for the disease to debut over the age of 60 and when it does, it is less severe.

"We therefore sought to ascertain the incidence of in older age groups and if there is any difference in how they are treated and how they use the healthcare services," says Åsa Hallqvist Everhov, researcher at Karolinska Institutet's Department of Clinical Research and Education, Stockholm South General (Söder) Hospital (KI SÖS) and at the same hospital.

The study included all new cases of inflammatory bowel disease in Sweden between 2006 and 2014. The resulting group of just under 28,000 patients was split into three sub-groups depending on year of onset: childhood (<18), adult (18-59) and old adult (?60). Data were sourced from the National Board of Health and Welfare's patients and prescribed drugs registers, subject to a maximum monitoring period of nine years. The researchers compared the patients' healthcare consumption with that of a matched group selected from the general population.

Just over one fifth of the participants were over 60. The study also shows that this group consumed more healthcare than the two younger groups and more than their matched peers without inflammatory disease. They were also operated on more often and sooner after disease onset, often already within the first year.

"It's common, in other words, for the disease to onset after the age of 60 and we found no evidence that when it does, the disease progress is milder," says Dr Hallqvist Everhov.

One important finding was the big difference in medication between the age groups. More younger patients received modern immunomodulating drugs and TNF inhibitors, whereas older cortisone drugs were more commonly given to the older patients.

"We don't know the reason for this, but it could be due either to under-prescription to older sufferers or to prudent choice, since the newer drugs carry certain risks and side-effects," continues Dr. Hallqvist Everhov. "Older patients often already have other potent drugs."

The researchers plan to examine the causes of the treatment discrepancies in a new study.

Explore further: Inflammatory bowel disease in childhood associated with increased risk of cancer

More information: Åsa H. Everhov et al, Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.10.034

Related Stories

Inflammatory bowel disease in childhood associated with increased risk of cancer

September 21, 2017
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) run a higher risk of cancer, both in childhood and later in life, a study from Karolinska Institutet published in the BMJ reports.

Asthma tied to later inflammatory bowel disease

August 25, 2017
(HealthDay)—Asthma is associated with subsequent development of inflammatory bowel disease (IBD), according to a study published in the September issue of Clinical Gastroenterology and Hepatology.

More patients with ulcerative colitis but fewer surgeries

October 17, 2017
Today, a higher number of patients with ulcerative colitis are able to keep their bowel and steer clear of surgery, as shown in a study from Örebro University. Carl Eriksson, doctoral student at Örebro University, has also ...

Smoking may cause inflammatory bowel disease

October 31, 2017
A new study shows a direct effect of cigarette smoke on intestinal inflammation for the first time. Researchers in South Korea report that exposing mice to cigarette smoke results in colitis, an inflammation of the colon ...

Cytokine controls immune cells that trigger inflammatory bowel disease, study finds

April 18, 2017
A certain cytokine, or small protein that helps cells communicate during immune responses, can control whether immune cells promote or suppress inflammatory bowel disease, a finding that could lead to new treatments, according ...

High incidence of bowel disease seen in people with lung conditions

November 18, 2014
People with airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), have a higher incidence of inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, according to the findings ...

Recommended for you

Metabolites altered in chronic kidney disease

November 22, 2017
Chronic kidney disease (CKD) affects 1 in 7 people in the United States, according to the U.S. National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). These individuals have a very high risk of cardiovascular ...

Rainfall can indicate that mosquito-borne epidemics will occur weeks later

November 22, 2017
A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.Researchers also found that Chikungunya will predominate over Zika when both circulate ...

Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease

November 22, 2017
A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population. The findings, which are published in Hepatology, indicate ...

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.